Interest in magic mushrooms and psilocybin has grown dramatically in recent years. At the same time, many people interested in psychedelics take prescription medications for depression, anxiety, ADHD, bipolar disorder, pain, sleep, or other conditions.

That creates an important question:

What happens when psychedelics and prescription medications are combined?

The answer isn’t always straightforward.

Psilocybin primarily affects the brain’s serotonin system, particularly the 5-HT2A receptor. Many common medications influence serotonin or related brain systems as well. Combining substances that act on the same pathways can potentially change the effects of either substance, increase side effects, or create more serious risks.

Research into psychedelic drug interactions is still developing. One major limitation is that many clinical trials historically excluded people taking certain psychiatric medications, meaning researchers have less direct evidence about these combinations than many people realize. (PubMed Central (PMC))

Psilocybin and the Serotonin System

Psilocybin itself is converted in the body into psilocin, the compound largely responsible for its psychedelic effects.

Psilocin interacts strongly with serotonin receptors, especially the 5-HT2A receptor.

Serotonin is involved in numerous functions, including:

• Mood
• Perception
• Sleep
• Anxiety
• Cognition
• Appetite
• Sensory processing

Many psychiatric medications also alter serotonin signaling.

This doesn’t automatically mean that every serotonergic medication is dangerous when combined with psilocybin. The actual interaction depends on the medication, its mechanism, the individual, and other factors.

What it does mean is that medication use should be taken seriously when discussing psychedelics.

SSRIs and Magic Mushrooms

Selective serotonin reuptake inhibitors, better known as SSRIs, are among the most commonly prescribed antidepressants.

Examples include medications such as sertraline, escitalopram, fluoxetine, and others.

Because both SSRIs and psilocybin involve serotonin signaling, their interaction has received considerable attention.

One commonly repeated claim is that SSRIs simply “block” magic mushrooms.

The science is more complicated.

A retrospective survey of people who used psilocybin mushrooms while taking antidepressants found that people taking SSRIs or SNRIs frequently reported weaker-than-expected psychedelic effects. (PubMed)

However, controlled research has not consistently shown that SSRIs completely eliminate psilocybin’s effects. A small clinical study examining psilocybin in people who continued taking an SSRI did not identify major new safety problems, although the study was small and cannot establish that every combination is safe. (PubMed)

The important takeaway is that SSRI–psilocybin interactions remain an active area of research.

Don’t Stop Antidepressants Just to Take Psychedelics

This point is extremely important.

Someone taking an antidepressant should not abruptly stop their medication simply because they are considering using psilocybin.

Stopping certain antidepressants suddenly can cause withdrawal or discontinuation symptoms and may also cause the underlying condition being treated to worsen.

Researchers studying psilocybin have sometimes tapered participants off antidepressants, but these medication changes occur within structured research protocols and under medical supervision.

A medication prescribed by a doctor should only be reduced or discontinued with appropriate medical guidance. (PubMed Central (PMC))

SNRIs

Serotonin-norepinephrine reuptake inhibitors, or SNRIs, affect both serotonin and norepinephrine.

As with SSRIs, there is evidence that SNRIs may alter or reduce the subjective effects of psilocybin mushrooms.

In one retrospective study, people taking SSRIs and SNRIs were more likely to report weaker-than-expected mushroom effects than people taking the non-serotonergic antidepressant bupropion. (PubMed)

But again, reduced effects are only part of the discussion.

The overall safety of combining psychedelic substances with different antidepressants has not been established well enough to assume that every combination is harmless.

MAO Inhibitors Deserve Particular Attention

Monoamine oxidase inhibitors (MAOIs) are another class of medications that interact with neurotransmitter systems.

MAO enzymes normally help break down several neurotransmitters and psychoactive compounds.

Blocking these enzymes can significantly change how certain substances are metabolized and how strongly they affect the body.

Because of this mechanism, MAOIs can produce important drug interactions with numerous medications and psychoactive substances.

Reviews of psychedelic drug interactions therefore identify MAOIs as a class requiring particular caution. (PubMed Central (PMC))

This is one area where trying to predict the interaction based simply on someone’s previous psychedelic experiences is especially unreliable.

Lithium and Psychedelics Are a Major Red Flag

One of the more concerning medication interactions reported in the psychedelic literature involves lithium.

Lithium is commonly used as a mood stabilizer, particularly in the treatment of bipolar disorder.

Researchers analyzing online reports of people combining lithium with classic psychedelics found an unusually high number of reports involving seizures and medical emergencies.

In an analysis of 62 online reports involving lithium and classic psychedelics, 47% described seizures and 39% involved seeking medical attention. (PubMed)

There are major limitations to this evidence.

These were self-reported experiences collected from websites rather than a controlled clinical trial, and only a minority of the lithium reports specifically involved psilocybin.

So the numbers should not be interpreted as meaning that someone taking lithium has a 47% chance of experiencing a seizure from psilocybin.

However, the signal was concerning enough that researchers concluded that combining lithium and classic psychedelics may pose a significant seizure risk. A 2024 review of psychedelics and seizures also identified lithium and other co-administered substances as potential factors that can increase risk. (PubMed)

For anyone prescribed lithium, this is not an interaction to experiment with casually.

Antipsychotic Medications

Some antipsychotic medications interact with the same serotonin receptors involved in psychedelic effects.

Certain antipsychotics act as 5-HT2A receptor antagonists, essentially opposing one of the primary mechanisms through which psilocin produces its effects.

Research has shown that 5-HT2A antagonism can substantially reduce or block some of psilocybin’s subjective effects. (PubMed Central (PMC))

That doesn’t mean someone should change their antipsychotic medication in an attempt to make a psychedelic “work.”

These medications may be treating serious psychiatric conditions, and suddenly stopping them can itself carry significant risks.

Stimulants and Other Medications

Prescription stimulants and other medications affecting norepinephrine, dopamine, blood pressure, or heart rate create another layer of complexity.

Psychedelics themselves can temporarily change physiological measures such as blood pressure and heart rate.

A systematic review of psychiatric medication interactions with psilocybin and related psychedelics identified antidepressants, mood stabilizers, antipsychotics, psychostimulants, anxiolytics, and several other medication classes as areas where interactions deserve consideration. (PubMed Central (PMC))

Unfortunately, there isn’t a comprehensive clinical trial for every possible medication combination.

That uncertainty is itself important.

The absence of a documented interaction does not necessarily mean an interaction has been proven safe.

What About Serotonin Syndrome?

You’ll often hear serotonin syndrome mentioned when psychedelics and antidepressants are discussed.

Serotonin syndrome is a potentially serious condition caused by excessive serotonin activity.

Because psilocybin and several medications affect serotonergic signaling, researchers have historically considered serotonin toxicity when establishing psychedelic clinical-trial medication restrictions.

However, the risk needs to be described accurately.

Published reviews note that there has been a lack of documented serotonin-toxicity cases involving psilocybin in controlled research, and limited studies involving concurrent SSRIs have not demonstrated the dramatic interaction sometimes claimed online. (PubMed Central (PMC))

That doesn’t prove that every serotonergic combination is safe.

It means the evidence is still developing, and claims that serotonin syndrome is inevitable whenever an SSRI and psilocybin are combined are not supported by current research.

More Isn’t the Solution to a Blunted Experience

Another potential problem occurs when someone taking medication experiences weaker psychedelic effects than expected.

It can be tempting to assume:

“My medication is blocking it, so I just need more.”

That can be dangerous reasoning.

Individual mushrooms can vary chemically, medications may affect people differently, and increasing exposure in an attempt to overcome an interaction can make the eventual response far less predictable.

A weaker-than-expected experience does not establish how the body will react to a larger amount.

Medication Interactions Aren’t Just About Intensity

When people discuss drug interactions, they often focus entirely on whether something will make a psychedelic experience “stronger” or “weaker.”

Safety is much broader than that.

An interaction could potentially affect:

• Blood pressure
• Heart rate
• Body temperature
• Anxiety
• Sedation
• Seizure threshold
• Serotonin signaling
• Judgment
• Coordination
• Medication effectiveness
• Psychiatric stability

Two substances can also affect different systems simultaneously.

That is why predicting interactions based solely on subjective effects can be misleading.

Why Psychedelic Research Has So Many Screening Questions

Modern psychedelic research typically involves extensive medical and psychological screening.

Researchers want to know about medications, cardiovascular conditions, psychiatric history, seizure history, other substances being used, and numerous additional factors before administering a psychedelic.

This level of screening is one reason the results from controlled clinical studies shouldn’t automatically be assumed to apply to every situation outside a research environment.

The carefully selected participant in a clinical trial can be very different from someone taking several medications with multiple underlying health conditions.

Science Still Has a Lot to Learn

One of the most important things to understand about psilocybin is just how much remains unknown.

A 2024 systematic review examining interactions between classic psychedelics and other drugs found only 10 psilocybin interaction studies among the studies that met its criteria. (PubMed Central (PMC))

That’s surprisingly little considering the enormous number of prescription medications available.

Many psychedelic clinical trials have historically removed interacting medications from the equation rather than studying every possible combination.

Researchers are beginning to investigate these questions more directly, but there are still substantial gaps in the evidence.

The Bottom Line

Magic mushrooms aren’t pharmacologically isolated from everything else a person puts into their body.

Psilocybin and psilocin interact with real neurological systems, and prescription medications can interact with those same systems.

Some medications may reduce psychedelic effects. Others may alter them. Certain combinations could potentially create more significant health risks.

Lithium is one combination that has generated particular concern because of reports involving seizures. MAOIs and other strongly serotonergic medications also deserve careful consideration. SSRI and SNRI interactions appear more complicated than the simple claim that they’re either completely safe or completely incompatible with psilocybin.

Most importantly, do not abruptly stop, skip, taper, or change a prescribed medication in order to use a psychedelic.

Someone taking prescription medication who is considering psychedelics should discuss possible interactions with a qualified healthcare professional who understands their complete medication and medical history.

Research into psychedelics is moving quickly, and our understanding of these interactions will continue to evolve.

---

Important Safety Note

This article is provided for educational purposes only and is not medical advice or an instruction to use psilocybin or other psychedelics. Medication interactions can vary significantly between individuals. Never discontinue or alter a prescription medication without consulting the healthcare professional responsible for your care.